These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
¨
|
Transition Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
|
|
|
|
|
Delaware
|
|
22-3240619
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
1111 Marcus Avenue
Lake Success, New York
|
|
11042
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
|
|
|
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
|
Part I - Financial Information
|
Page
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
|
|
|
|
Part II - Other Information
|
|
|
|
|
|
|
Items 3, 4 and 5 are not applicable
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 6.
|
||
|
|
|
|
|
|
||
|
|
||
|
|
March 31,
|
|
June 30,
|
||||
|
|
2015
|
|
2014
|
||||
|
ASSETS
|
(Unaudited)
|
|
(Note)
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
100,325
|
|
|
$
|
123,751
|
|
|
Accounts receivable, less allowance for doubtful accounts of $2,142 and $1,586
|
337,516
|
|
|
287,915
|
|
||
|
Inventories
|
369,968
|
|
|
320,251
|
|
||
|
Deferred income taxes
|
26,581
|
|
|
23,780
|
|
||
|
Prepaid expenses and other current assets
|
46,514
|
|
|
47,906
|
|
||
|
Total current assets
|
880,904
|
|
|
803,603
|
|
||
|
Property, plant and equipment, net
|
325,966
|
|
|
310,661
|
|
||
|
Goodwill
|
1,107,328
|
|
|
1,134,368
|
|
||
|
Trademarks and other intangible assets, net
|
631,866
|
|
|
651,482
|
|
||
|
Investments and joint ventures
|
3,449
|
|
|
36,511
|
|
||
|
Other assets
|
31,686
|
|
|
28,692
|
|
||
|
Total assets
|
$
|
2,981,199
|
|
|
$
|
2,965,317
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
226,497
|
|
|
$
|
239,162
|
|
|
Accrued expenses and other current liabilities
|
82,319
|
|
|
84,906
|
|
||
|
Current portion of long-term debt
|
33,870
|
|
|
100,096
|
|
||
|
Total current liabilities
|
342,686
|
|
|
424,164
|
|
||
|
Long-term debt, less current portion
|
845,103
|
|
|
767,827
|
|
||
|
Deferred income taxes
|
159,743
|
|
|
148,439
|
|
||
|
Other noncurrent liabilities
|
5,834
|
|
|
5,020
|
|
||
|
Total liabilities
|
1,353,366
|
|
|
1,345,450
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Preferred stock - $.01 par value, authorized 5,000,000 shares, no shares issued
|
—
|
|
|
—
|
|
||
|
Common stock - $.01 par value, authorized 150,000,000 shares, issued 105,826,674 and 103,143,018 shares (see Note 2)
|
1,058
|
|
|
1,031
|
|
||
|
Additional paid-in capital (see Note 2)
|
1,064,341
|
|
|
969,182
|
|
||
|
Retained earnings
|
726,442
|
|
|
629,618
|
|
||
|
Accumulated other comprehensive income (loss)
|
(105,937
|
)
|
|
60,128
|
|
||
|
|
1,685,904
|
|
|
1,659,959
|
|
||
|
Less: 3,228,136 and 2,906,160 shares of treasury stock, at cost (See Note 2)
|
(58,071
|
)
|
|
(40,092
|
)
|
||
|
Total stockholders’ equity
|
1,627,833
|
|
|
1,619,867
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
2,981,199
|
|
|
$
|
2,965,317
|
|
|
|
Three Months Ended March 31,
|
|
Nine Months Ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Net sales
|
$
|
662,739
|
|
|
$
|
557,420
|
|
|
$
|
1,990,379
|
|
|
$
|
1,569,783
|
|
|
Cost of sales
|
504,990
|
|
|
404,627
|
|
|
1,539,459
|
|
|
1,154,790
|
|
||||
|
Gross profit
|
157,749
|
|
|
152,793
|
|
|
450,920
|
|
|
414,993
|
|
||||
|
Selling, general and administrative expenses
|
83,068
|
|
|
78,268
|
|
|
262,613
|
|
|
227,092
|
|
||||
|
Amortization/impairment of acquired intangibles
|
10,189
|
|
|
4,133
|
|
|
19,001
|
|
|
11,248
|
|
||||
|
Acquisition related expenses, restructuring and integration charges, net
|
4,298
|
|
|
6,763
|
|
|
6,273
|
|
|
8,939
|
|
||||
|
Operating income
|
60,194
|
|
|
63,629
|
|
|
163,033
|
|
|
167,714
|
|
||||
|
Interest and other expenses, net
|
8,640
|
|
|
5,946
|
|
|
21,380
|
|
|
15,839
|
|
||||
|
Income before income taxes and equity in earnings of equity-method investees
|
51,554
|
|
|
57,683
|
|
|
141,653
|
|
|
151,875
|
|
||||
|
Provision for income taxes
|
18,147
|
|
|
19,748
|
|
|
45,144
|
|
|
48,247
|
|
||||
|
Equity in net loss (income) of equity-method investees
|
13
|
|
|
(83
|
)
|
|
(315
|
)
|
|
(2,128
|
)
|
||||
|
Income from continuing operations
|
33,394
|
|
|
38,018
|
|
|
96,824
|
|
|
105,756
|
|
||||
|
Discontinued operations
|
—
|
|
|
(2,777
|
)
|
|
—
|
|
|
(1,629
|
)
|
||||
|
Net income
|
$
|
33,394
|
|
|
$
|
35,241
|
|
|
$
|
96,824
|
|
|
$
|
104,127
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic net income per common share:
|
|
|
|
|
|
|
|
||||||||
|
From continuing operations
|
$
|
0.33
|
|
|
$
|
0.38
|
|
|
$
|
0.95
|
|
|
$
|
1.09
|
|
|
From discontinued operations
|
—
|
|
|
(0.03
|
)
|
|
—
|
|
|
(0.02
|
)
|
||||
|
Net income per common share - basic
|
$
|
0.33
|
|
|
$
|
0.35
|
|
|
$
|
0.95
|
|
|
$
|
1.07
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted net income per common share:
|
|
|
|
|
|
|
|
||||||||
|
From continuing operations
|
$
|
0.32
|
|
|
$
|
0.37
|
|
|
$
|
0.94
|
|
|
$
|
1.07
|
|
|
From discontinued operations
|
—
|
|
|
(0.03
|
)
|
|
—
|
|
|
(0.02
|
)
|
||||
|
Net income per common share - diluted
|
$
|
0.32
|
|
|
$
|
0.34
|
|
|
$
|
0.94
|
|
|
$
|
1.05
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Shares used in the calculation of net income per common share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
102,252
|
|
|
99,390
|
|
|
101,401
|
|
|
96,946
|
|
||||
|
Diluted
|
103,796
|
|
|
101,502
|
|
|
103,226
|
|
|
99,246
|
|
||||
|
|
Three Months Ended
|
||||||||||||||||||||||
|
|
March 31, 2015
|
|
March 31, 2014
|
||||||||||||||||||||
|
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
||||||||||||
|
Net income
|
|
|
|
|
$
|
33,394
|
|
|
|
|
|
|
$
|
35,241
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign currency translation adjustments
|
$
|
(59,603
|
)
|
|
$
|
2,485
|
|
|
(57,118
|
)
|
|
$
|
6,390
|
|
|
$
|
1,132
|
|
|
7,522
|
|
||
|
Change in deferred gains (losses) on cash flow hedging instruments
|
382
|
|
|
(130
|
)
|
|
252
|
|
|
262
|
|
|
(64
|
)
|
|
198
|
|
||||||
|
Change in unrealized gain on available for sale investment
|
(175
|
)
|
|
54
|
|
|
(121
|
)
|
|
(929
|
)
|
|
286
|
|
|
(643
|
)
|
||||||
|
Total other comprehensive income (loss)
|
$
|
(59,396
|
)
|
|
$
|
2,409
|
|
|
$
|
(56,987
|
)
|
|
$
|
5,723
|
|
|
$
|
1,354
|
|
|
$
|
7,077
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total comprehensive (loss) income
|
|
|
|
|
$
|
(23,593
|
)
|
|
|
|
|
|
$
|
42,318
|
|
||||||||
|
|
Nine Months Ended
|
||||||||||||||||||||||
|
|
March 31, 2015
|
|
March 31, 2014
|
||||||||||||||||||||
|
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
|
Pre-tax
amount
|
|
Tax benefit
|
|
After-tax amount
|
||||||||||||
|
Net income
|
|
|
|
|
$
|
96,824
|
|
|
|
|
|
|
$
|
104,127
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign currency translation adjustments
|
$
|
(172,301
|
)
|
|
$
|
5,214
|
|
|
(167,087
|
)
|
|
65,055
|
|
|
1,478
|
|
|
66,533
|
|
||||
|
Change in deferred gains (losses) on cash flow hedging instruments
|
2,687
|
|
|
(656
|
)
|
|
2,031
|
|
|
82
|
|
|
(21
|
)
|
|
61
|
|
||||||
|
Change in unrealized gain on available for sale investment
|
(1,518
|
)
|
|
509
|
|
|
(1,009
|
)
|
|
(2,013
|
)
|
|
704
|
|
|
(1,309
|
)
|
||||||
|
Total other comprehensive income (loss)
|
$
|
(171,132
|
)
|
|
$
|
5,067
|
|
|
$
|
(166,065
|
)
|
|
$
|
63,124
|
|
|
$
|
2,161
|
|
|
$
|
65,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total comprehensive (loss) income
|
|
|
|
|
$
|
(69,241
|
)
|
|
|
|
|
|
$
|
169,412
|
|
||||||||
|
|
Common Stock
|
|
Additional
|
|
|
|
|
|
|
|
Accumulated
Other
|
|
|
||||||||||||||||
|
|
|
|
Amount
|
|
Paid-in
|
|
Retained
|
|
Treasury Stock
|
|
Comprehensive
|
|
|
||||||||||||||||
|
|
Shares
|
|
at $.01
|
|
Capital
|
|
Earnings
|
|
Shares
|
|
Amount
|
|
Income (Loss)
|
|
Total
|
||||||||||||||
|
Balance at June 30, 2014
|
103,143,018
|
|
|
$
|
1,031
|
|
|
$
|
969,182
|
|
|
$
|
629,618
|
|
|
2,906,160
|
|
|
$
|
(40,092
|
)
|
|
$
|
60,128
|
|
|
$
|
1,619,867
|
|
|
Net income
|
|
|
|
|
|
|
96,824
|
|
|
|
|
|
|
|
|
96,824
|
|
||||||||||||
|
Other comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
(166,065
|
)
|
|
(166,065
|
)
|
||||||||||||
|
Issuance of common stock pursuant to compensation plans
|
1,953,816
|
|
|
20
|
|
|
26,065
|
|
|
|
|
|
|
|
|
|
|
|
26,085
|
|
|||||||||
|
Issuance of common stock in connection with acquisitions
|
729,840
|
|
|
7
|
|
|
34,129
|
|
|
|
|
|
|
|
|
|
|
34,136
|
|
||||||||||
|
Stock based compensation income tax effects
|
|
|
|
|
26,031
|
|
|
|
|
|
|
|
|
|
|
26,031
|
|
||||||||||||
|
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans
|
|
|
|
|
|
|
|
|
321,976
|
|
|
(17,979
|
)
|
|
|
|
(17,979
|
)
|
|||||||||||
|
Stock based compensation charge
|
|
|
|
|
8,934
|
|
|
|
|
|
|
|
|
|
|
8,934
|
|
||||||||||||
|
Balance at March 31, 2015
|
105,826,674
|
|
|
$
|
1,058
|
|
|
$
|
1,064,341
|
|
|
$
|
726,442
|
|
|
3,228,136
|
|
|
$
|
(58,071
|
)
|
|
$
|
(105,937
|
)
|
|
$
|
1,627,833
|
|
|
|
Nine Months Ended March 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
||||
|
Net income
|
$
|
96,824
|
|
|
$
|
104,127
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
43,064
|
|
|
34,597
|
|
||
|
Deferred income taxes
|
(5,789
|
)
|
|
(2,573
|
)
|
||
|
Equity in net income of equity-method investees
|
(315
|
)
|
|
(2,128
|
)
|
||
|
Stock based compensation
|
8,934
|
|
|
9,656
|
|
||
|
Tax benefit from stock based compensation
|
341
|
|
|
1,366
|
|
||
|
Contingent consideration expense
|
280
|
|
|
(1,379
|
)
|
||
|
Gain on sale of business
|
—
|
|
|
1,629
|
|
||
|
Gains on pre-existing ownership interests in HPPC and Empire
|
(8,256
|
)
|
|
—
|
|
||
|
Non-cash intangible asset impairment charge
|
5,510
|
|
|
—
|
|
||
|
Other non-cash items, net
|
4,652
|
|
|
(437
|
)
|
||
|
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
|
|
|
|
||||
|
Accounts receivable
|
(59,583
|
)
|
|
(18,326
|
)
|
||
|
Inventories
|
(15,106
|
)
|
|
(4,986
|
)
|
||
|
Other current assets
|
4,050
|
|
|
(573
|
)
|
||
|
Other assets and liabilities
|
(8,708
|
)
|
|
(3,007
|
)
|
||
|
Accounts payable and accrued expenses
|
4,271
|
|
|
4,315
|
|
||
|
Net cash provided by operating activities
|
70,169
|
|
|
122,281
|
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
||||
|
Acquisitions of businesses, net of cash acquired and working capital settlements
|
(104,419
|
)
|
|
(121,499
|
)
|
||
|
Purchases of property and equipment
|
(36,312
|
)
|
|
(30,724
|
)
|
||
|
Repayments from equity-method investees, net
|
—
|
|
|
6,038
|
|
||
|
Proceeds from sale of investment
|
1,488
|
|
|
2,201
|
|
||
|
Proceeds from disposals of property and equipment
|
1,703
|
|
|
—
|
|
||
|
Net cash used in investing activities
|
(137,540
|
)
|
|
(143,984
|
)
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
||||
|
Proceeds from exercises of stock options
|
18,643
|
|
|
7,203
|
|
||
|
Borrowings under bank revolving credit facility, net
|
82,000
|
|
|
91,424
|
|
||
|
Repayments of other debt, net
|
(50,090
|
)
|
|
(22,126
|
)
|
||
|
Excess tax benefits from stock based compensation
|
25,692
|
|
|
14,130
|
|
||
|
Acquisition related contingent consideration
|
(3,217
|
)
|
|
—
|
|
||
|
Shares withheld for payment of employee payroll taxes
|
(17,979
|
)
|
|
(10,021
|
)
|
||
|
Net cash provided by financing activities
|
55,049
|
|
|
80,610
|
|
||
|
|
|
|
|
||||
|
Effect of exchange rate changes on cash
|
(11,104
|
)
|
|
1,252
|
|
||
|
|
|
|
|
||||
|
Net (decrease) increase in cash and cash equivalents
|
(23,426
|
)
|
|
60,159
|
|
||
|
Cash and cash equivalents at beginning of period
|
123,751
|
|
|
41,263
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
100,325
|
|
|
$
|
101,422
|
|
|
|
Three Months Ended March 31,
|
|
Nine Months Ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Numerator:
|
|
|
|
|
|
|
|
||||||||
|
Income from continuing operations
|
$
|
33,394
|
|
|
$
|
38,018
|
|
|
$
|
96,824
|
|
|
$
|
105,756
|
|
|
Discontinued operations
|
—
|
|
|
(2,777
|
)
|
|
—
|
|
|
(1,629
|
)
|
||||
|
Net income
|
$
|
33,394
|
|
|
$
|
35,241
|
|
|
$
|
96,824
|
|
|
$
|
104,127
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator (in thousands):
|
|
|
|
|
|
|
|
||||||||
|
Denominator for basic earnings per share - weighted average shares outstanding during the period
|
102,252
|
|
|
99,390
|
|
|
101,401
|
|
|
96,946
|
|
||||
|
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units
|
1,544
|
|
|
2,112
|
|
|
1,825
|
|
|
2,300
|
|
||||
|
Denominator for diluted earnings per share - adjusted weighted average shares and assumed conversions
|
103,796
|
|
|
101,502
|
|
|
103,226
|
|
|
99,246
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Basic net income per common share:
|
|
|
|
|
|
|
|
|
|
||||||
|
From continuing operations
|
$
|
0.33
|
|
|
$
|
0.38
|
|
|
$
|
0.95
|
|
|
$
|
1.09
|
|
|
From discontinued operations
|
—
|
|
|
(0.03
|
)
|
|
—
|
|
|
(0.02
|
)
|
||||
|
Net income per common share - basic
|
$
|
0.33
|
|
|
$
|
0.35
|
|
|
$
|
0.95
|
|
|
$
|
1.07
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted net income per common share:
|
|
|
|
|
|
|
|
||||||||
|
From continuing operations
|
$
|
0.32
|
|
|
$
|
0.37
|
|
|
$
|
0.94
|
|
|
$
|
1.07
|
|
|
From discontinued operations
|
—
|
|
|
(0.03
|
)
|
|
—
|
|
|
(0.02
|
)
|
||||
|
Net income per common share - diluted
|
$
|
0.32
|
|
|
$
|
0.34
|
|
|
$
|
0.94
|
|
|
$
|
1.05
|
|
|
|
HPPC
|
|
Belvedere
|
|
Empire
|
|
Total
|
||||||||
|
Carrying value of pre-existing interest, after fair value adjustments:
|
$
|
36,074
|
|
|
$
|
—
|
|
|
$
|
9,786
|
|
|
$
|
45,860
|
|
|
Purchase Price:
|
|
|
|
|
|
|
|
||||||||
|
Cash paid
|
20,310
|
|
|
13,776
|
|
|
57,595
|
|
|
91,681
|
|
||||
|
Equity issued
|
19,690
|
|
|
—
|
|
|
—
|
|
|
19,690
|
|
||||
|
Fair value of contingent consideration
|
—
|
|
|
1,603
|
|
|
—
|
|
|
1,603
|
|
||||
|
Total investment:
|
$
|
76,074
|
|
|
$
|
15,379
|
|
|
$
|
67,381
|
|
|
$
|
158,834
|
|
|
Allocation:
|
|
|
|
|
|
|
|
||||||||
|
Current assets
|
$
|
52,055
|
|
|
$
|
10,332
|
|
|
$
|
19,741
|
|
|
$
|
82,128
|
|
|
Property, plant and equipment
|
21,864
|
|
|
2,479
|
|
|
13,095
|
|
|
37,438
|
|
||||
|
Other assets
|
7,288
|
|
|
—
|
|
|
—
|
|
|
7,288
|
|
||||
|
Identifiable intangible assets
|
20,700
|
|
|
5,698
|
|
|
34,020
|
|
|
60,418
|
|
||||
|
Deferred taxes
|
999
|
|
|
(3,630
|
)
|
|
(13,739
|
)
|
|
(16,370
|
)
|
||||
|
Assumed liabilities
|
(41,615
|
)
|
|
(1,424
|
)
|
|
(13,948
|
)
|
|
(56,987
|
)
|
||||
|
Goodwill
|
14,783
|
|
|
1,924
|
|
|
28,212
|
|
|
44,919
|
|
||||
|
|
$
|
76,074
|
|
|
$
|
15,379
|
|
|
$
|
67,381
|
|
|
$
|
158,834
|
|
|
|
Three Months ended March 31,
|
|
Nine Months ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Net sales from continuing operations
|
$
|
687,902
|
|
|
$
|
649,213
|
|
|
$
|
2,099,232
|
|
|
$
|
1,873,452
|
|
|
Net income from continuing operations
|
$
|
34,179
|
|
|
$
|
38,956
|
|
|
$
|
100,058
|
|
|
$
|
110,888
|
|
|
Net income per common share from continuing operations - diluted
|
$
|
0.33
|
|
|
$
|
0.38
|
|
|
$
|
0.97
|
|
|
$
|
1.11
|
|
|
|
Tilda
|
|
Rudi’s
|
|
Total
|
||||||
|
Purchase price:
|
|
|
|
|
|
||||||
|
Cash paid
|
$
|
123,822
|
|
|
$
|
50,807
|
|
|
$
|
174,629
|
|
|
Equity issued
|
148,353
|
|
|
11,168
|
|
|
159,521
|
|
|||
|
Vendor Loan Note
|
32,958
|
|
|
—
|
|
|
32,958
|
|
|||
|
|
$
|
305,133
|
|
|
$
|
61,975
|
|
|
$
|
367,108
|
|
|
Allocation:
|
|
|
|
|
|
||||||
|
Current assets
|
$
|
86,828
|
|
|
$
|
8,058
|
|
|
$
|
94,886
|
|
|
Property, plant and equipment
|
39,806
|
|
|
3,774
|
|
|
43,580
|
|
|||
|
Identifiable intangible assets
|
124,549
|
|
|
27,514
|
|
|
152,063
|
|
|||
|
Assumed liabilities
|
(92,971
|
)
|
|
(6,332
|
)
|
|
(99,303
|
)
|
|||
|
Deferred income taxes
|
(26,195
|
)
|
|
(37
|
)
|
|
(26,232
|
)
|
|||
|
Goodwill
|
173,116
|
|
|
28,998
|
|
|
202,114
|
|
|||
|
|
$
|
305,133
|
|
|
$
|
61,975
|
|
|
$
|
367,108
|
|
|
|
Three Months Ended March 31, 2014
|
|
Nine Months Ended March 31, 2014
|
||||
|
Net sales from continuing operations
|
$
|
572,905
|
|
|
$
|
1,723,757
|
|
|
Net income from continuing operations
|
$
|
38,139
|
|
|
$
|
117,874
|
|
|
Net income per common share from continuing operations - diluted
|
$
|
0.37
|
|
|
$
|
1.15
|
|
|
|
March 31,
2015 |
|
June 30,
2014 |
||||
|
Finished goods
|
$
|
221,234
|
|
|
$
|
190,818
|
|
|
Raw materials, work-in-progress and packaging
|
148,734
|
|
|
129,433
|
|
||
|
|
$
|
369,968
|
|
|
$
|
320,251
|
|
|
|
March 31,
2015 |
|
June 30,
2014 |
||||
|
Land
|
$
|
35,052
|
|
|
$
|
34,021
|
|
|
Buildings and improvements
|
83,304
|
|
|
75,895
|
|
||
|
Machinery and equipment
|
344,747
|
|
|
329,680
|
|
||
|
Furniture and fixtures
|
9,813
|
|
|
10,352
|
|
||
|
Leasehold improvements
|
19,331
|
|
|
21,836
|
|
||
|
Construction in progress
|
8,852
|
|
|
4,850
|
|
||
|
|
501,099
|
|
|
476,634
|
|
||
|
Less: Accumulated depreciation and amortization
|
175,133
|
|
|
165,973
|
|
||
|
|
$
|
325,966
|
|
|
$
|
310,661
|
|
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Total
|
||||||||||
|
Balance as of June 30, 2014 (a)
|
$
|
607,326
|
|
|
$
|
457,818
|
|
|
$
|
—
|
|
|
$
|
69,224
|
|
|
$
|
1,134,368
|
|
|
Acquisition activity
|
5,711
|
|
|
—
|
|
|
42,995
|
|
|
1,924
|
|
|
50,630
|
|
|||||
|
Translation and other adjustments, net
|
(5,228
|
)
|
|
(61,767
|
)
|
|
—
|
|
|
(10,675
|
)
|
|
(77,670
|
)
|
|||||
|
Balance as of March 31, 2015 (a)
|
$
|
607,809
|
|
|
$
|
396,051
|
|
|
$
|
42,995
|
|
|
$
|
60,473
|
|
|
$
|
1,107,328
|
|
|
|
March 31,
2015 |
|
June 30,
2014 |
||||
|
Non-amortized intangible assets:
|
|
|
|
||||
|
Trademarks and tradenames
|
$
|
494,606
|
|
|
$
|
498,068
|
|
|
Amortized intangible assets:
|
|
|
|
||||
|
Other intangibles
|
198,386
|
|
|
206,071
|
|
||
|
Less: accumulated amortization
|
(61,126
|
)
|
|
(52,657
|
)
|
||
|
Net carrying amount
|
$
|
631,866
|
|
|
$
|
651,482
|
|
|
|
Three Months ended March 31,
|
|
Nine Months ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Amortization of intangible assets
|
$
|
4,679
|
|
|
$
|
4,133
|
|
|
$
|
13,491
|
|
|
$
|
11,248
|
|
|
|
Fiscal Year ended June 30,
|
||||||||||||||||||
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
||||||||||
|
Estimated amortization expense
|
$
|
17,033
|
|
|
$
|
16,204
|
|
|
$
|
16,045
|
|
|
$
|
14,363
|
|
|
$
|
12,828
|
|
|
|
March 31,
2015 |
|
June 30,
2014 |
||||
|
Senior Notes
|
$
|
150,000
|
|
|
$
|
150,000
|
|
|
Revolving Credit Agreement borrowings payable to banks
|
692,443
|
|
|
614,502
|
|
||
|
Tilda short-term borrowing arrangements
|
33,391
|
|
|
65,975
|
|
||
|
Vendor Loan Note
(see note 4)
|
—
|
|
|
34,056
|
|
||
|
Other borrowings
|
3,139
|
|
|
3,390
|
|
||
|
|
878,973
|
|
|
867,923
|
|
||
|
Short-term borrowings and current portion of long-term debt
|
33,870
|
|
|
100,096
|
|
||
|
|
$
|
845,103
|
|
|
$
|
767,827
|
|
|
|
Three Months Ended
March 31,
|
|
Nine Months Ended
March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss) before reclassifications
(1)
|
$
|
(57,118
|
)
|
|
$
|
7,522
|
|
|
$
|
(167,087
|
)
|
|
$
|
66,533
|
|
|
Amounts reclassified into income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Deferred gains/(losses) on cash flow hedging instruments:
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss) before reclassifications
|
750
|
|
|
587
|
|
|
5,179
|
|
|
847
|
|
||||
|
Amounts reclassified into income
(2)
|
(498
|
)
|
|
(389
|
)
|
|
(3,148
|
)
|
|
(786
|
)
|
||||
|
Unrealized gain on available for sale investment:
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss) before reclassifications
|
(120
|
)
|
|
(358
|
)
|
|
(819
|
)
|
|
(881
|
)
|
||||
|
Amounts reclassified into income
(3)
|
(1
|
)
|
|
(285
|
)
|
|
(190
|
)
|
|
(428
|
)
|
||||
|
Net change in accumulated other comprehensive income (loss)
|
$
|
(56,987
|
)
|
|
$
|
7,077
|
|
|
$
|
(166,065
|
)
|
|
$
|
65,285
|
|
|
(1)
|
Foreign currency translation adjustments include intra-entity foreign currency transactions that are of a long-term investment nature of
$21,210
and
$1,670
for the three months ended
March 31, 2015
and
2014
,
respectively,
and
$64,316
and
$17,604
for the nine months ended
March 31, 2015
and
2014
, respectively.
|
|
(2)
|
Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were
$711
and
$525
for the three months ended
March 31, 2015
and
2014
, respectively, and
$4,126
and
$1,053
for the nine months ended
March 31, 2015
and
2014
, respectively.
|
|
(3)
|
Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 13). Such amounts are recorded in “Interest and other expenses, net” in the Condensed Consolidated Statements of Income and were
$1
and
$468
before taxes for the three months ended
March 31, 2015
and
2014
, respectively and
$312
and
$702
for the nine months ended
March 31, 2015
and
2014
, respectively.
|
|
|
Three Months Ended March 31,
|
|
Nine Months Ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Compensation cost (included in selling, general and administrative expense)
|
$
|
2,935
|
|
|
$
|
3,020
|
|
|
$
|
8,934
|
|
|
$
|
9,656
|
|
|
Related income tax benefit
|
$
|
1,125
|
|
|
$
|
1,144
|
|
|
$
|
3,438
|
|
|
$
|
3,690
|
|
|
|
Number of Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Contractual
Life (years)
|
|
Aggregate Intrinsic Value
|
|||
|
Options outstanding and exercisable at June 30, 2014
|
2,674,290
|
|
|
$9.83
|
|
|
|
|
||
|
Exercised
|
(1,425,378
|
)
|
|
$13.08
|
|
|
|
|
||
|
Options outstanding and exercisable at March 31, 2015
|
1,248,912
|
|
|
$6.12
|
|
2.6 years
|
|
$
|
72,355
|
|
|
|
Nine Months Ended March 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Intrinsic value of options exercised
|
$
|
62,213
|
|
|
$
|
29,521
|
|
|
Cash received from stock option exercises
|
$
|
18,643
|
|
|
$
|
7,203
|
|
|
Tax benefit recognized from stock option exercises
|
$
|
24,213
|
|
|
$
|
11,484
|
|
|
|
Number of Shares and Units
|
|
Weighted
Average Grant
Date Fair
Value
(per share)
|
|
|
Non-vested restricted stock and restricted share units at June 30, 2014
|
1,258,744
|
|
|
$25.44
|
|
Granted
|
268,596
|
|
|
$53.07
|
|
Vested
|
(399,188
|
)
|
|
$26.75
|
|
Forfeited
|
(18,356
|
)
|
|
$39.54
|
|
Non-vested restricted stock and restricted share units at March 31, 2015
|
1,109,796
|
|
|
$31.43
|
|
|
Nine Months Ended March 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Fair value of restricted stock and restricted share units granted
|
$
|
14,255
|
|
|
$
|
9,048
|
|
|
Fair value of shares vested
|
$
|
21,303
|
|
|
$
|
19,902
|
|
|
Tax benefit recognized from restricted shares vesting
|
$
|
8,294
|
|
|
$
|
7,534
|
|
|
•
|
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
|
|
•
|
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;
|
|
•
|
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
|
|
|
Total
|
|
Quoted
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents
|
$
|
15,100
|
|
|
$
|
15,100
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Forward foreign currency contracts
|
2,270
|
|
|
—
|
|
|
2,270
|
|
|
—
|
|
||||
|
Available for sale securities
|
2,620
|
|
|
2,620
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
19,990
|
|
|
$
|
17,720
|
|
|
$
|
2,270
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Forward foreign currency contracts
|
$
|
380
|
|
|
$
|
—
|
|
|
$
|
380
|
|
|
$
|
—
|
|
|
Contingent consideration, of which $3,704 is noncurrent
|
3,704
|
|
|
—
|
|
|
—
|
|
|
3,704
|
|
||||
|
Total
|
$
|
4,084
|
|
|
$
|
—
|
|
|
$
|
380
|
|
|
$
|
3,704
|
|
|
|
Total
|
|
Quoted
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents
|
$
|
31,902
|
|
|
$
|
31,902
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Forward foreign currency contracts
|
391
|
|
|
—
|
|
|
391
|
|
|
—
|
|
||||
|
Available for sale securities
|
5,314
|
|
|
5,314
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
37,607
|
|
|
$
|
37,216
|
|
|
$
|
391
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Forward foreign currency contracts
|
$
|
1,168
|
|
|
$
|
—
|
|
|
$
|
1,168
|
|
|
$
|
—
|
|
|
Contingent consideration, of which $2,669 is noncurrent
|
8,280
|
|
|
—
|
|
|
—
|
|
|
8,280
|
|
||||
|
Total
|
$
|
9,448
|
|
|
$
|
—
|
|
|
$
|
1,168
|
|
|
$
|
8,280
|
|
|
|
Nine Months Ended March 31, 2015
|
||
|
Balance as of June 30, 2014
|
$
|
8,280
|
|
|
Fair value of initial contingent consideration
|
1,603
|
|
|
|
Contingent consideration adjustment
|
280
|
|
|
|
Contingent consideration paid
|
(5,477
|
)
|
|
|
Translation adjustment
|
(982
|
)
|
|
|
Balance as of March 31, 2015
|
$
|
3,704
|
|
|
|
Three Months Ended March 31,
|
|
Nine Months Ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
Net Sales:
|
|
|
|
|
|
|
|
||||||||
|
United States
|
$
|
343,728
|
|
|
$
|
319,471
|
|
|
$
|
1,034,612
|
|
|
$
|
959,191
|
|
|
United Kingdom
|
178,068
|
|
|
176,939
|
|
|
551,144
|
|
|
436,985
|
|
||||
|
Hain Pure Protein
|
83,192
|
|
|
—
|
|
|
240,078
|
|
|
—
|
|
||||
|
Rest of World
|
57,751
|
|
|
61,010
|
|
|
164,545
|
|
|
173,607
|
|
||||
|
|
$
|
662,739
|
|
|
$
|
557,420
|
|
|
$
|
1,990,379
|
|
|
$
|
1,569,783
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating Income:
|
|
|
|
|
|
|
|
||||||||
|
United States
|
$
|
55,851
|
|
|
$
|
56,702
|
|
|
$
|
141,031
|
|
|
$
|
159,578
|
|
|
United Kingdom
|
11,760
|
|
|
18,366
|
|
|
29,618
|
|
|
32,278
|
|
||||
|
Hain Pure Protein
|
4,970
|
|
|
—
|
|
|
16,505
|
|
|
—
|
|
||||
|
Rest of World
|
4,412
|
|
|
5,100
|
|
|
10,660
|
|
|
11,544
|
|
||||
|
|
$
|
76,993
|
|
|
$
|
80,168
|
|
|
$
|
197,814
|
|
|
$
|
203,400
|
|
|
Corporate and other
(1)
|
(16,799
|
)
|
|
(16,539
|
)
|
|
(34,781
|
)
|
|
(35,686
|
)
|
||||
|
|
$
|
60,194
|
|
|
$
|
63,629
|
|
|
$
|
163,033
|
|
|
$
|
167,714
|
|
|
(1)
|
Includes
$4,263
and
$6,882
of acquisition related expenses, restructuring and integration charges for the three months ended
March 31, 2015
and
2014
, respectively. Such expenses for the nine months ended March 31, 2015 and 2014 were
$5,925
and
$9,885
, respectively. Corporate and other also includes expense of
$280
and a net reduction of expense of
$1,936
for contingent consideration adjustments for the nine months ended
March 31, 2015
and
2014
, respectively. A non-cash impairment charge of
$5,510
for the three and nine months ended
March 31, 2015
related to a United Kingdom indefinite-lived intangible asset is also included in Corporate and other.
|
|
|
March 31,
2015 |
|
June 30,
2014 |
||||
|
United States
|
$
|
147,300
|
|
|
$
|
139,919
|
|
|
Canada
|
11,091
|
|
|
9,694
|
|
||
|
United Kingdom
|
181,319
|
|
|
198,505
|
|
||
|
Europe
|
21,391
|
|
|
27,746
|
|
||
|
|
$
|
361,101
|
|
|
$
|
375,864
|
|
|
|
Three Months Ended
|
||||||||||
|
|
March 31, 2015
|
|
March 31, 2014
|
||||||||
|
Net sales
|
$
|
662,739
|
|
|
100.0%
|
|
$
|
557,420
|
|
|
100.0%
|
|
Cost of sales
|
504,990
|
|
|
76.2%
|
|
404,627
|
|
|
72.6%
|
||
|
Gross profit
|
157,749
|
|
|
23.8%
|
|
152,793
|
|
|
27.4%
|
||
|
|
|
|
|
|
|
|
|
||||
|
Selling, general and administrative expenses
|
83,068
|
|
|
12.5%
|
|
78,268
|
|
|
14.0%
|
||
|
Amortization/impairment of acquired intangibles
|
10,189
|
|
|
1.5%
|
|
4,133
|
|
|
0.7%
|
||
|
Acquisition related expenses, restructuring and integration charges, net
|
4,298
|
|
|
0.6%
|
|
6,763
|
|
|
1.2%
|
||
|
Operating income
|
60,194
|
|
|
9.1%
|
|
63,629
|
|
|
11.4%
|
||
|
Interest and other expenses, net
|
8,640
|
|
|
1.3%
|
|
5,946
|
|
|
1.1%
|
||
|
Income before income taxes and equity in earnings of equity-method investees
|
51,554
|
|
|
7.8%
|
|
57,683
|
|
|
10.3%
|
||
|
Provision for income taxes
|
18,147
|
|
|
2.7%
|
|
19,748
|
|
|
3.5%
|
||
|
Equity in net loss (income) of equity-method investees
|
13
|
|
|
—%
|
|
(83
|
)
|
|
—%
|
||
|
Income from continuing operations
|
33,394
|
|
|
5.0%
|
|
38,018
|
|
|
6.8%
|
||
|
Discontinued operations
|
—
|
|
|
—%
|
|
(2,777
|
)
|
|
(0.5)%
|
||
|
Net income
|
$
|
33,394
|
|
|
5.0%
|
|
$
|
35,241
|
|
|
6.3%
|
|
(dollars in thousands)
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Corporate and other
(1)
|
|
Consolidated
|
||||||||||||
|
Net sales - Three months ended 3/31/15
|
|
$
|
343,728
|
|
|
$
|
178,068
|
|
|
$
|
83,192
|
|
|
$
|
57,751
|
|
|
$
|
—
|
|
|
$
|
662,739
|
|
|
Net sales - Three months ended 3/31/14
|
|
$
|
319,471
|
|
|
$
|
176,939
|
|
|
$
|
—
|
|
|
$
|
61,010
|
|
|
$
|
—
|
|
|
$
|
557,420
|
|
|
% change
|
|
7.6
|
%
|
|
0.6
|
%
|
|
|
|
|
(5.3
|
)%
|
|
|
|
18.9
|
%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Operating income - Three months ended 3/31/15
|
|
$
|
55,851
|
|
|
$
|
11,760
|
|
|
$
|
4,970
|
|
|
$
|
4,412
|
|
|
$
|
(16,799
|
)
|
|
$
|
60,194
|
|
|
Operating income - Three months ended 3/31/14
|
|
$
|
56,702
|
|
|
$
|
18,366
|
|
|
$
|
—
|
|
|
$
|
5,100
|
|
|
$
|
(16,539
|
)
|
|
$
|
63,629
|
|
|
% change
|
|
(1.5
|
)%
|
|
(36.0
|
)%
|
|
|
|
|
(13.5
|
)%
|
|
|
|
(5.4
|
)%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Operating income margin - Three months ended 3/31/15
|
|
16.2
|
%
|
|
6.6
|
%
|
|
6.0
|
%
|
|
7.6
|
%
|
|
|
|
9.1
|
%
|
|||||||
|
Operating income margin - Three months ended 3/31/14
|
|
17.7
|
%
|
|
10.4
|
%
|
|
|
|
|
8.4
|
%
|
|
|
|
11.4
|
%
|
|||||||
|
(1)
|
Includes
$4,263
and
$6,882
of acquisition related expenses, restructuring and integration charges for the three months ended
March 31, 2015
and
2014
, respectively. A non-cash impairment charge of
$5,510
for the three and nine months ended
March 31, 2015
related to an indefinite-lived intangible asset in the United Kingdom segment is also included in Corporate and other.
|
|
|
Nine Months Ended
|
|||||||||||
|
|
March 31, 2015
|
|
March 31, 2014
|
|||||||||
|
Net sales
|
$
|
1,990,379
|
|
|
100.0%
|
|
$
|
1,569,783
|
|
|
100.0%
|
|
|
Cost of sales
|
1,539,459
|
|
|
77.3%
|
|
1,154,790
|
|
|
73.6%
|
|||
|
Gross profit
|
450,920
|
|
|
22.7%
|
|
414,993
|
|
|
26.4%
|
|||
|
|
|
|
|
|
|
|
—
|
|
||||
|
Selling, general and administrative expenses
|
262,613
|
|
|
13.2%
|
|
227,092
|
|
|
14.5%
|
|||
|
Amortization/impairment of acquired intangibles
|
19,001
|
|
|
1.0%
|
|
11,248
|
|
|
0.7%
|
|||
|
Acquisition related expenses, restructuring and integration charges
|
6,273
|
|
|
0.3%
|
|
8,939
|
|
|
0.6%
|
|||
|
Operating income
|
163,033
|
|
|
8.2%
|
|
167,714
|
|
|
10.7%
|
|||
|
Interest and other expenses, net
|
21,380
|
|
|
1.1%
|
|
15,839
|
|
|
1.0%
|
|||
|
Income before income taxes and equity in earnings of equity-method investees
|
141,653
|
|
|
7.1%
|
|
151,875
|
|
|
9.7%
|
|||
|
Provision for income taxes
|
45,144
|
|
|
2.3%
|
|
48,247
|
|
|
3.1%
|
|||
|
Equity in net (income) of equity-method investees
|
(315
|
)
|
|
—%
|
|
(2,128
|
)
|
|
(0.1)%
|
|||
|
Income from continuing operations
|
96,824
|
|
|
4.9%
|
|
105,756
|
|
|
6.7%
|
|||
|
Discontinued operations
|
—
|
|
|
—%
|
|
(1,629
|
)
|
|
(0.1)%
|
|||
|
Net income
|
$
|
96,824
|
|
|
4.9%
|
|
$
|
104,127
|
|
|
6.6%
|
|
|
(dollars in thousands)
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Corporate and other
(1)
|
|
Consolidated
|
||||||||||||
|
Net sales - Nine months ended 3/31/15
|
|
$
|
1,034,612
|
|
|
$
|
551,144
|
|
|
$
|
240,078
|
|
|
$
|
164,545
|
|
|
$
|
—
|
|
|
$
|
1,990,379
|
|
|
Net sales - Nine months ended 3/31/14
|
|
$
|
959,191
|
|
|
$
|
436,985
|
|
|
$
|
—
|
|
|
$
|
173,607
|
|
|
$
|
—
|
|
|
$
|
1,569,783
|
|
|
% change
|
|
7.9
|
%
|
|
26.1
|
%
|
|
|
|
(5.2
|
)%
|
|
|
|
26.8
|
%
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Operating income - Nine months ended 3/31/15
|
|
$
|
141,031
|
|
|
$
|
29,618
|
|
|
$
|
16,505
|
|
|
$
|
10,660
|
|
|
$
|
(34,781
|
)
|
|
$
|
163,033
|
|
|
Operating income - Nine months ended 3/31/14
|
|
$
|
159,578
|
|
|
$
|
32,278
|
|
|
$
|
—
|
|
|
$
|
11,544
|
|
|
$
|
(35,686
|
)
|
|
$
|
167,714
|
|
|
% change
|
|
(11.6
|
)%
|
|
(8.2
|
)%
|
|
|
|
(7.7
|
)%
|
|
|
|
(2.8
|
)%
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Operating income margin - Nine months ended 3/31/15
|
|
13.6
|
%
|
|
5.4
|
%
|
|
6.9
|
%
|
|
6.5
|
%
|
|
|
|
8.2
|
%
|
|||||||
|
Operating income margin - Nine months ended 3/31/14
|
|
16.6
|
%
|
|
7.4
|
%
|
|
|
|
6.6
|
%
|
|
|
|
10.7
|
%
|
||||||||
|
(1)
|
Includes
$5,925
and
$9,885
of acquisition related expenses, restructuring and integration charges for the nine months ended
March 31, 2015
and
2014
, respectively. Corporate and other also includes expense of
$280
for contingent consideration adjustments for the nine months ended
March 31, 2015
. Corporate and other also includes expense of
$280
and a net reduction of expense of
$1,936
for contingent consideration adjustments for the nine months ended
March 31, 2015
and
2014
, respectively. A non-cash impairment charge of
$5,510
for the three and nine months ended
March 31, 2015
related to an indefinite-lived intangible asset in the the United Kingdom segment is also included in Corporate and other.
|
|
|
Nine Months Ended March 31,
|
||||||
|
(amounts in thousands)
|
2015
|
|
2014
|
||||
|
Cash flows provided by (used in):
|
|
|
|
||||
|
Operating activities
|
$
|
70,169
|
|
|
$
|
122,281
|
|
|
Investing activities
|
(137,540
|
)
|
|
(143,984
|
)
|
||
|
Financing activities
|
55,049
|
|
|
80,610
|
|
||
|
Exchange rate changes
|
(11,104
|
)
|
|
1,252
|
|
||
|
Net (decrease) increase in cash
|
$
|
(23,426
|
)
|
|
$
|
60,159
|
|
|
|
Nine Months Ended March 31,
|
||||||
|
(amounts in thousands)
|
2015
|
|
2014
|
||||
|
Cash flow provided by operating activities
|
$
|
70,169
|
|
|
$
|
122,281
|
|
|
Purchase of property, plant and equipment
|
(36,312
|
)
|
|
(30,724
|
)
|
||
|
Operating free cash flow
|
$
|
33,857
|
|
|
$
|
91,557
|
|
|
•
|
our ability to achieve our guidance for net sales and earnings per diluted share in fiscal year 2015 given the economic environment in the U.S. and other markets that we sell products as well as economic, political and business conditions generally and their effect on our customers and consumers' product preferences, and our business, financial condition and results of operations;
|
|
•
|
changes in estimates or judgments related to our impairment analysis of goodwill and other intangible assets, as well as with respect to the Company's valuation allowances of its deferred tax assets;
|
|
•
|
our ability to implement our business and acquisition strategy;
|
|
•
|
the ability of our joint venture investment to successfully execute its business plan;
|
|
•
|
our ability to realize sustainable growth generally and from investments in core brands, offering new products and our focus on cost containment, productivity, cash flow and margin enhancement in particular;
|
|
•
|
our ability to effectively integrate our acquisitions;
|
|
•
|
our ability to successfully consummate any proposed divestitures;
|
|
•
|
the effects on our results of operations from the impacts of foreign exchange;
|
|
•
|
competition;
|
|
•
|
the success and cost of introducing new products as well as our ability to increase prices on existing products;
|
|
•
|
availability and retention of key personnel;
|
|
•
|
our reliance on third party distributors, manufacturers and suppliers;
|
|
•
|
our ability to maintain existing customers and secure and integrate new customers;
|
|
•
|
our ability to respond to changes and trends in customer and consumer demand, preferences and consumption;
|
|
•
|
risks associated with international sales and operations;
|
|
•
|
changes in fuel, raw material and commodity costs;
|
|
•
|
ability to offset input cost increases;
|
|
•
|
changes in, or the failure to comply with, government laws and regulations;
|
|
•
|
the availability of organic and natural ingredients;
|
|
•
|
the loss of one or more of our manufacturing facilities, independent co-packers or distribution centers;
|
|
•
|
our ability to manage our supply chain effectively;
|
|
•
|
our ability to use our trademarks;
|
|
•
|
reputational damage;
|
|
•
|
product liability;
|
|
•
|
outbreaks of diseases or other food-borne illnesses;
|
|
•
|
product recall or market withdrawal;
|
|
•
|
seasonality;
|
|
•
|
litigation;
|
|
•
|
the Company's reliance on its information technology systems; and
|
|
•
|
the other risk factors described in Item 1A below and in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.
|
|
Period
|
(a)
Total number
of shares
purchased
|
|
(b)
Average
price paid
per share
|
|
(c)
Total number of
shares purchased
as part of
publicly
announced plans
|
|
(d)
Maximum
number of shares
that may yet be
purchased under
the plans
|
|||||
|
January 2015
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
—
|
|
|
February 2015
(1)
|
97,518
|
|
|
59.48
|
|
|
—
|
|
|
—
|
|
|
|
March 2015
(2)
|
86
|
|
|
63.17
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
97,604
|
|
|
$
|
59.48
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Shares repurchased to cover cost of a stock option exercise.
|
|
(2)
|
Shares surrendered for payment of employee payroll taxes due on shares issued under stockholder approved stock based compensation plans.
|
|
|
|
THE HAIN CELESTIAL GROUP, INC.
|
|
|
|
|
|
Date:
|
May 11, 2015
|
/s/ Irwin D. Simon
|
|
|
|
Irwin D. Simon,
Chairman, President and Chief
Executive Officer
|
|
Date:
|
May 11, 2015
|
/s/ Stephen J. Smith
|
|
|
|
Stephen J. Smith,
Executive Vice President and
Chief Financial Officer
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
|
|
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
|
|
|
|
|
|
32.1
|
|
Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.2
|
|
Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101
|
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statement of Stockholders’ Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|